Brainlab Quentry First Online Medical Platform to Receive EuroPriSe European Data Privacy Seal

Brainlab AGBrainlab, a global leader in medical technology, today announced that it has received the EuroPriSe European Data Privacy Seal for Quentry® by Brainlab. The seal certifies that Quentry is compliant with data protection directives implemented by all European states.

Quentry enables medical professionals to share images, display the images in a web-based viewer and add comments such as medical opinions. Quentry supports clinicians throughout the referral, review, planning and treatment workflow, supporting patient data management and collaboration. Quentry is the first cloud-based medical service to receive certification from EuroPriSe.

Addressing regulations on privacy and data security for all European states, EuroPriSe certification required a rigorous, two-year evaluation process. Quentry underwent this robust audit, which improved upon and validated the platform’s technical and organizational measures and multilayered encryption technology embedded in the architecture.

Quentry employs advanced encryption and access control technologies that approximate the level of a true end-to-end encryption to the greatest extent possible. This safeguards that all sensitive medical information is protected. Data uploaded and stored on Quentry can only be accessed and viewed by authorized individuals.

"With an increasing number of worldwide data security breaches, protecting patient and user data is vital to any cloud-based medical platform," said Rainer Birkenbach, Executive Vice President. "Brainlab developers built a multi-layered encryption system, which protects all patient data against unjustified inspection - even service providers and administrators are not able to individually decrypt data. Our goal was to go above and beyond the most stringent requirements for high-level data protection that customers and government regulators demand with Quentry. We’re pleased to see our efforts rewarded by EuroPriSe."

The responsibility for the lawful processing of patient data lies with the users of the service. They are advised by Brainlab that the legitimate use of Quentry requires the collection of patients' informed consent and release from medical confidentiality and that they are obliged to verify the identity of other users in a reliable way prior to sharing medical information with them.

"Brainlab expended a great deal of effort in order to ensure the confidentiality of sensitive data," says Sebastian Meissner, Head of the EuroPriSe Certification Authority. Meissner said positive aspects of Quentry include, "comprehensive privacy hints provided to users and the ability to de-identify meta data about patients."

The EuroPriSe seal is valid for two years, and will continuously be re-evaluated when new features and functionalities are added to Quentry.

About Brainlab
Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.

Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.

Privately held since its formation in Munich, Germany in 1989, Brainlab has more than 9,000 systems installed in about 100 countries. Brainlab employs 1,300 people in 18 offices worldwide, including 320 Research & Development engineers, who form a crucial part of the product development team.

About EuroPriSe
EuroPriSe started as an EU-funded project aimed at establishing a trans-European privacy seal. Today, EuroPriSe offers certifications for IT products, IT-based services and websites throughout the EU. A unique certification, the EuroPriSe seal assures users that their personal data are handled in accordance with European data protection laws. As the only EU-wide, independent privacy seal, EuroPriSe enables enterprises to demonstrate their compliance with European laws and regulations. EuroPriSe certifications have been awarded to businesses of all sizes, including small and medium-sized companies as well as multinational organizations such as Microsoft and SAP.

Most Popular Now

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...

Does AI Improve Doctors' Diagnoses?

With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the accuracy of doctors' diagnoses when...

AI Analysis of PET/CT Images can Predict…

Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious...